☰

Laura A. Laviolette, Ph.D. - Publications

Affiliations: 
2011 Cellular and Molecular Medicine University of Ottawa, Ottawa, ON, Canada 
Area:
Oncology, Pathology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Laviolette LA, Hodgkinson KM, Minhas N, Perez-Iratxeta C, Vanderhyden BC. 17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo. International Journal of Cancer. Journal International Du Cancer. 135: 1072-84. PMID 24469735 DOI: 10.1002/Ijc.28741  0.643
2013 Laviolette LA, Wilson J, Koller J, Neil C, Hulick P, Rejtar T, Karger B, Teh BT, Iliopoulos O. Human Folliculin Delays Cell Cycle Progression through Late S and G2/M-Phases: Effect of Phosphorylation and Tumor Associated Mutations Plos One. 8. PMID 23874397 DOI: 10.1371/Journal.Pone.0066775  0.368
2013 Laviolette LA, Wilson J, Koller J, Neil C, Hulick P, Rejtar T, Karger B, Teh BT, Iliopoulos O. Tumor-associated FLCN mutations fail to delay cell cycle progression. Plos One. DOI: 10.1371/Journal.Pone.0066775.G003  0.383
2012 Laviolette LA, Wilson J, Koller J, Zimmer M, Iliopoulos O. Abstract 2171: Human FLCN delays cell cycle progression through late S and G2/M-phases: Effect of phosphorylation and tumor-associated mutations Cancer Research. 72: 2171-2171. DOI: 10.1158/1538-7445.Am2012-2171  0.399
2012 Vuong NH, Macdonald E, Hodgkinson K, Laviolette LA, Vanderhyden BC. Mechanisms by Which Estrogen Accelerates Ovarian Tumor Initiation. Biology of Reproduction. 87: 548-548. DOI: 10.1093/Biolreprod/87.S1.548  0.578
2011 Laviolette LA, Ethier JF, Senterman MK, Devine PJ, Vanderhyden BC. Induction of a menopausal state alters the growth and histology of ovarian tumors in a mouse model of ovarian cancer. Menopause (New York, N.Y.). 18: 549-57. PMID 21221022 DOI: 10.1097/Gme.0B013E3181Fca1B6  0.645
2011 Hodgkinson KM, Laviolette L, Perez-Iratxeta C, Vanderhyden BC. Reproductive Steroid Hormones Alter Ovarian Cancer Progression in Mouse Models. Biology of Reproduction. 85: 343-343. DOI: 10.1093/Biolreprod/85.S1.343  0.641
2010 Laviolette LA, Garson K, Macdonald EA, Senterman MK, Courville K, Crane CA, Vanderhyden BC. 17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer. Endocrinology. 151: 929-38. PMID 20056833 DOI: 10.1210/en.2009-0602  0.657
2008 Laviolette LA, Garson K, Macdonald EA, Senterman MK, Courville K, Vanderhyden BC. Exogenous 17β-estradiol Results in an Earlier Onset of Ovarian Cancer and a Decreased Survival Time in a Transgenic Mouse Model of Ovarian Cancer. Biology of Reproduction. 78: 179-179. DOI: 10.1093/Biolreprod/78.S1.179  0.615
Show low-probability matches.